Article
Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein.
Hepatology (Baltimore, Md.) - 1 May 2013
Westhaus Sandra, Bankwitz Dorothea, Ernst Stefanie, Rohrmann Katrin, Wappler Ilka, Agné Clemens, Luchtefeld Maren, Schieffer Bernhard, Sarrazin Christoph, Manns Michael P, Pietschmann Thomas, Ciesek Sandra, von Hahn Thomas
Abstract excerpt
UNLABELLED: Oxidized low-density lipoprotein (oxLDL) has been reported as an inhibitor of hepatitis C virus (HCV) cell entry, making it the only known component of human lipid metabolism with an antiviral effect on HCV. However, several questions remain open, including its effect on full-length cell-culture-grown HCV (HCVcc) of different genotypes or on other steps of the viral replication cycle, its mechanism of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
